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This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive 
summary of evidence. 
 
COVID-19 Preparedness and Response 
Publication 
date 
Title/URL Journal/Article 
type 
Summary 
28.04.2020 Early transmission 
dynamics of novel 
coronavirus (COVID-
19) in Nigeria 
Int J Environ 
Res Public 
Health | Article 
 Preliminary epidemiological 
analysis of the first 45 days of 
COVID-19 outbreak in Nigeria 
estimates the reproduction 
number peaking at 5.61 (95% 
CrI 3.83 – 7.88) at day 25 (22 
March 2020). The median 
reproduction number over the 
study period was 
2.71  lowering to 1.42 (95% 
Crl 1.26-1.58) on 11 April 
 These estimates are lower 
than expected  
 Preparedness to detect needs 
to move to stop local 
transmission  
27.04.2020 COVID-19 and 
Nigeria: Putting the 
realities in context 
Int J Infec Dis | 
Article 
 Nigeria’s preparedness for 
critical care of COVID-19 
remains poor and inadequate 
 COVID-19 cases and mortality 
are underreported due to poor 
surveillance  
 Strengthening infectious 
disease surveillance 
mechanisms and international 
2 
collaborations are key to halt 
the C19 pandemic 
28.04.2020 Hand cleaning with 
ash for reducing the 
spread of viral and 
bacterial infections: a 
rapid review 
Cochrane 
Database of 
Systematic 
Reviews 2020 
| Rapid 
Review 
 If hand cleaning with ash is 
effective, it could reduce the 
spread of COVID-19 in LMICs 
where soap is not widely 
available 
 Authors conclude though that 
it remains uncertain whether 
hand cleaning with ash 
compared with hand cleaning 
with soap, water, mud, soil or 
no hand cleaning stops or 
reduces the spread of viral or 
bacterial infections. 
 It also remains uncertain if 
washing with ash causes 
unwanted effects, like sore 
hands or a rash 
01.05.2020 COVID-19 in people 
living with human 
immunodeficiency 
virus: A case series 
of 33 patients 
medRxiv (not 
peer reviewed) 
| Article 
 Data on patients living with 
human immunodeficiency 
virus (PLWH) with COVID-19 
remains scare 
 Of the 32 patients with 
documented outcome, 91% 
recovered and 76% were 
classified as mild suggesting 
that there is no excess 
morbidity and mortality among 
PLWH and symptomatic 
COVID-19 
 All patients were on 
antiretroviral treatment 
28.04.2020 Sex-specific clinical 
characteristics and 
prognosis of 
coronavirus disease-
19 infection in 
Wuhan, China: a 
retrospective study 
of 168 severe 
patients 
PLoS 
Pathogens | 
Article 
(uncorrected 
proof) 
 A retrospective study of 168 
consecutive severe COVID-19 
confirmed patients in a 
hospital in Wuhan China found 
sex-specific differences in 
clinical characteristics and 
prognosis to COVID-19, 
consistent with the sex-bias 
observed in other studies 
  
  
3 
Guidelines, Statements & Tools 
Publication 
Date 
Title/URL Source   Description 
30.04.2020 COVID-19 and the Rights of 
Persons with Disabilities: 
Guidance 
UN Human 
Rights 
  
28.04.2020 COVI-PREG CHUV   International COVID-19 and 
Pregnancy   Registry 
28.04.2020 Accessibility Campaign – 
COVID-19 
International 
Disability 
Alliance 
  Call for PH information and 
communications around COVID-
19 to be fully accessible 
24.04.2020 Handwashing compendium 
for low resource settings: a 
living document (edition 1) 
IDS Sanitation 
Learning Hub 
  
Ongoing WHO Country & Technical 
Guidance 
WHO   
Ongoing Rapid guidelines and 
evidence summaries 
NICE   
Ongoing Inter-Agency Standing 
Committee (IASC) 
IASC   
Comments, Editorials, Opinions, Blogs, News  
Publication 
date 
Title/URL Journal | Article type Author(s) 
28.04.2020 Let Africa into the market for 
COVID-19 diagnostics 
Nature | World View John Nkengasong 
30.04.2020 COVID-19 reveals weak health 
systems by design: why we must 
re-make global health in this 
historic moment 
Global Public Health | 
Commentary 
Sriram 
Shamasunder et al. 
01.05.2020 Accountability for COVID-19 Aid: 
better visibility matters for the 
quality of the response  
Center for Global 
Development | Blog 
Janeen Madan 
Keller, Julia 
Kaufmann & 
Amanda Glassman 
01.05.2020 The COVID-19 response for 
vulnerable people in places 
affected by conflict and 
humanitarian crises 
The Lancet | 
Comment 
David Nott 
30.04.2020 A COVID-19 conference at AIDS 
2020: Virtual  
The Lancet | 
Comment 
  
30.04.2020 COVID-19: collateral damage of 
lockdown in India 
BMJ | Feature Bhavya Dore 
29.04.2020 Surveys show the COVID-19 has 
gendered effects in Asia and the 
Pacific 
UN Women | Survey 
preliminary results 
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30.04.2020 Considering BCG vaccination to 
reduce the impact of COVID-19 
The Lancet | 
Correspondence 
Nigel Curtis, Annie 
Sparrow, Tedros 
Ghebreyesus & 
Mihai Netea 
30.04.2020 Using social and behavioural 
science to support COVID-19 
pandemic response 
Nature Human 
Behaviour | 
Perspective 
Jay J. Van Bavel et 
al. 
29.04.2020 Rethinking research to respond to 
global challenges 
IDS | Opinion Peter Taylor 
29.04.2020 China and the future of global 
health governance 
IDS | Opinion Gerald Bloom 
30.04.2020 Insights from health systems under 
stress 
IDS | Opinion Tom Barker 
27.04.2020 What does Covid-19 mean for 
people with disabilities 
IDS | Opinion Mary Wickenden, 
Brigitte Rohwerder, 
Jackie Shaw & 
Stephen Thompson 
28.04.2020 Covid-19 lockdown in Zimbabwe: a 
disaster for farmers 
IDS | Opinion Ian Scoones 
29.04.2020 Moving personal protective 
equipment into the community: face 
shields and containment of COVID-
19 
JAMA | Viewpoint Eli N. Perencevich, 
Daniel J. Diekema 
& Michael B. 
Edmond 
21.04.2020 Gendering pandemics: identifying 
the unequal impacts of COVID-19 
IDS | Opinion Isabelle Tickel, 
Madhurima Sanyal 
& Rebeca Moreno 
Sandoval 
Tracking Dashboards 
Cases & 
deaths: 
Global 
Cases & 
deaths: 
Regional 
Cases & 
deaths: 
Country 
Living 
evidence 
maps 
Current 
studies 
including trials 
  Diagnosti
cs 
  Treatment
s 
  Vaccine
s 
WHO 
sitreps 
WHO 
Africa 
Ghana COVID-
NMA 
WHO   FIND 
SARS-
CoV-2 Test 
Tracker 
  Global 
COVID-19 
Clinical 
Trial 
Tracker 
  CEPI 
WHO 
dashboard 
African 
Argument
s 
Indonesi
a 
EPPI 
Centre 
WHO 
International 
Clinical Trials 
Registry 
Platform 
(ICTRP) 
  Serology-
based tests 
for COVID-
19 
  US NIH 
registered 
clinical 
trials 
Vaccine 
Centre 
LSHTM 
Johns 
Hopkins 
University 
European 
CDC 
Nigeria 
CDC 
Norwegia
n 
Institute 
Cytel     Solidarity 
trial 
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of Public 
Health 
WEF 
  Sierra 
Leone 
  US NIH     COVID-19 
Therapeuti
cs 
Accelerator 
  
Our World 
in Data 
  Singapor
e 
  COVID-
evidence 
      
Global 
5050 
  UK   Cochrane       
CEBM, 
University 
of Oxford 
  US   Clinicaltrials.g
ov 
      
Humanitari
an Data 
Exchange 
              
Information 
is Beautiful 
              
LSHTM               
HealthMap 
(cases) 
              
The 
Commons 
Project 
              
C19 Resource Hubs  
Global  Region
al & 
Country 
Academi
c journals 
& 
Publisher
s 
Global Health 
Institutes/Centres/Funders/O
ther 
Health 
Topics 
  Social 
Sciences 
WHO COVID-
19 pandemic  
Africa 
CDC 
The 
Lancet 
LSTM Stop TB 
Partnership 
  SSHAP 
WHO risk 
communicatio
n 
African 
Union 
NEJM LSHTM 
 
  IDA 
WHO Q&A Nigeria 
CDC 
Elsevier ICL MRC Centre for Global 
Infectious Disease Analysis  
Global 
Menstrual 
Collective  
  Disability 
and 
inclusion 
WHO Global 
research 
GeoPoll
: SSA 
BMJ ODI SLH: 
Handwashi
ng in low 
resource 
settings 
  Coregrou
p IDDC 
COVID-19 
Solidarity 
Global 
Health 
Cell 
Press 
Johns Hopkins University 
 
  Rings 
HSG 
6 
Response 
Fund 
Network 
Africa 
Resyst 
Reach 
Wellcome 
UN African 
Academ
y of 
Science
s 
Cochran
e 
resource
s 
Center for Global 
Development 
    Social 
Developme
nt Direct 
C19 blog 
series 
UN Women Africa 
Evidenc
e 
Network 
PLoS CMMID Repository     
UNOCHA   Annals of 
Internal 
Medicine 
Norwegian Institute of Public 
Health 
    
UNHCR     Oxford Centre for Evidence-
based Medicine 
    
UNICEF      HEART     
UNESCO   Wiley 
Health 
Economi
cs 
 UKRI     
UN WFP   Pre-
prints 
medRxiv 
and 
bioRxiv 
 Evidence Aid     
GOARN           
EPI-WIN           
World Bank           
COVID-19 
Narratives by 
David 
Nabarro 
          
Reliefweb           
Humanitarian 
OpenStreetM
ap Team 
          
Global 
Partnership 
for 
Sustainable 
Development 
Data 
          
WorldPop           
Flowminder           
COVID-END           
7 
Premise 
COVID-19 
Global Impact 
Study 
    
  
Online learning & events 
Date Title/URL Online 
learning/event 
Duration Lead 
Available 
now 
Emerging respiratory 
viruses, including 
COVID-19: methods 
for detection, 
prevention, response 
and control 
Online learning 3 hours WHO 
Available 
now 
Responding to 
COVID-19: Real-time 
training for the 
coronavirus disease 
outbreak 
Online learning Multiple self-
paced 
course 
WHO 
25 May 
2020 
COVID-19: Tackling 
the Novel 
Coronavirus 
Online learning 3 weeks | 4 
hours 
weekly 
study 
FutureLearn LSHTM/UK 
PHRST 
20 April 
2020 
COVID-19 
Diagnostics and 
Testing 
Online learning 3 weeks | 3 
hours 
weekly 
study 
FutureLearn 
FIND/LSHTM/ASLM 
6 April 
2020 
COVID-19 Critical 
Care: Understanding 
and Application 
Online learning 5 weeks | 1 
hour weekly 
study 
FutureLearn University 
of Edinburgh & Royal 
College of Physicians of 
Edinburgh  
Available 
now 
COVID-19 
supporting online 
courses 
Online learning Multiple self-
paced 
course 
BMJ Learning 
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